Patents by Inventor Michael W. Wathen

Michael W. Wathen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of preventing or treating atherosclerosis or restenosis
    Publication number: 20040186131
    Abstract: The present invention provides a method of preventing or treating atherosclerosis or restenosis in mammals, which comprises administering an effective amount of a compound selected from the group consisting of structures of Formulas I to XV: 1
    Type: Application
    Filed: August 28, 2003
    Publication date: September 23, 2004
    Inventors: Michael W. Wathen, Lynne K. Wathen
  • Method of preventing or treating atherosclerosis or restenosis
    Publication number: 20040176366
    Abstract: The present invention provides a method of preventing or treating atherosclerosis or restenosis in mammals, which comprises administering an effective amount of a compound selected from the group consisting of structures of Formulas X and XII-XV: 1
    Type: Application
    Filed: August 28, 2003
    Publication date: September 9, 2004
    Inventors: Michael W. Wathen, Lynne K. Wathen
  • Method for treating herpes viruses
    Publication number: 20040115623
    Abstract: The present invention relates to a method for selecting an anti-herpes viral compound and a method for selectively inhibiting herpesvrus in a human host in need of such treatment.
    Type: Application
    Filed: October 24, 2003
    Publication date: June 17, 2004
    Inventors: Fred L. Homa, Michael W. Wathen, Todd A. Hopkins, Darrell R. Thomsen
  • Method of preventing or treating atherosclerosis or restenosis
    Publication number: 20040102473
    Abstract: The present invention provides a method of treating atherosclerosis or restenosis in a mammal which comprises administering to said mammal an effective amount of a compound selected from the group consisting of structures of Formulae I, I′ and II, 1
    Type: Application
    Filed: August 28, 2003
    Publication date: May 27, 2004
    Inventors: Michael W. Wathen, Lynne K. Wathen
  • Method of preventing or treating atherosclerosis or restenosis
    Publication number: 20040067947
    Abstract: The present invention provides a method of preventing or treating atherosclerosis or restenosis in mammals, which comprises administering an effective amount of a compound selected from the group consisting of structures of Formulas VI, VII, VIII and IX: 1
    Type: Application
    Filed: August 28, 2003
    Publication date: April 8, 2004
    Inventors: Michael W. Wathen, Lynne K. Wathen
  • Method for treating herpes viruses
    Patent number: 6682892
    Abstract: The present invention relates to a method for selecting an anti-herpes viral compound and a method for selectively inhibiting herpesvrus in a human host in need of such treatment. The present invention relates to a method for selecting an anti-herpes viral compound and a method for selectively inhibiting herpesvrus in a human host in need of such treatment.
    Type: Grant
    Filed: July 12, 2001
    Date of Patent: January 27, 2004
    Assignee: Pharmacia & Upjohn Company
    Inventors: Fred L. Homa, Michael W. Wathen, Todd A. Hopkins, Darrell R. Thomsen
  • Method for treating herpes viruses
    Publication number: 20020076789
    Abstract: The present invention relates to a method for selecting an anti-herpes viral compound and a method for selectively inhibiting herpesvrus in a human host in need of such treatment.
    Type: Application
    Filed: July 12, 2001
    Publication date: June 20, 2002
    Inventors: Fred L. Homa, Michael W. Wathen, Todd A. Hopkins, Darrell R. Thomsen
  • Expression system for RSV glycoprotein F and G
    Patent number: 5288630
    Abstract: This invention encompasses DNA compositions encoding novel chimeric glycoproteins which are useful for preparing virus specific immune responses against human respiratory syncytial virus. The DNA compositions include structural genes coding for the glycoproteins and expression and replication plasmids containing the structural genes. Host cells transformed with the above DNA compositions, vaccines made from the glycoproteins and methods for protecting humans by inoculation with said vaccines are also part of this invention.
    Type: Grant
    Filed: November 20, 1992
    Date of Patent: February 22, 1994
    Assignee: The Upjohn Company
    Inventor: Michael W. Wathen
  • Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
    Patent number: 5284764
    Abstract: This invention encompasses novel chimeric glycoproteins which are useful for preparing virus specific immune responses against human parainfluenza virus type 3, PIV3. Host cells transformed with structural genes coding for the glycoproteins, expression and replication plasmids containing the structural genes, vaccines made from the glycoproteins and methods for protecting humans by inoculation with said vaccines are also part of this invention.
    Type: Grant
    Filed: September 4, 1992
    Date of Patent: February 8, 1994
    Assignee: The Upjohn Company
    Inventor: Michael W. Wathen
  • Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus
    Patent number: 5194595
    Abstract: This invention encompasses DNA compositions encoding novel chimeric glycoproteins which are useful for preparing virus specific immune responses against human respiratory syncytial virus. The DNA compositions include structural genes coding for the glycoproteins and expression and replication plasmids containing the structural genes. Host cells transformed with the above DNA compositions, vaccines made from the glycoproteins and methods for protecting humans by inoculation with said vaccines are also part of this invention.
    Type: Grant
    Filed: June 20, 1990
    Date of Patent: March 16, 1993
    Assignee: The Upjohn Company
    Inventor: Michael W. Wathen
  • Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
    Patent number: 5169628
    Abstract: This invention encompasses novel chimeric glycoproteins which are useful for preparing virus specific immune responses against human parainfluenza virus type 3, PIV3. Host cells transformed with structural genes coding for the glycoproteins, expression and replication plasmids containing the structural genes, vaccines made from the glycoproteins and methods for protecting humans by inoculation with said vaccines are also part of this invention.
    Type: Grant
    Filed: October 5, 1990
    Date of Patent: December 8, 1992
    Assignee: The Upjohn Company
    Inventor: Michael W. Wathen